We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why Hold Strategy is Apt for IDEX (IEX) Stock Now
Read MoreHide Full Article
IDEX Corporation (IEX - Free Report) benefits from the Fire & Safety/Diversified Products (FSD) segment and accretive acquisitions despite weakness in the Health & Science Technologies unit, rising cost of sales and forex woes.
Let us discuss the factors why investors should retain the stock for the time being.
Growth Catalysts
Business Strength: IEX’s FSD segment is being driven by strong momentum in the fire and rescue businesses. In the third quarter of 2023, the segmental adjusted EBITDA margin increased 210 bps due to strong price cost performance, operational productivity and favorable volume leverage.
Accretive Acquisition: The company’s expansion initiative is expected to drive growth. The acquisition of Iridian Spectral (May 2023) expanded IDEX’s wide array of optical technology offerings. Iridian is part of IDEX Optical Technologies within the Health & Science Technology segment.
In November 2022, the company completed the acquisition of Muon Group, expanding its growing platform of precision technology business within the Health & Science Technologies segment. Commercial synergy potential from the combined entities is expected to boost offerings for new and existing customers. Notably, acquired assets boosted the company’s sales by 3% in the third quarter. The company anticipates buyout synergies to boost sales by 2% in the fourth quarter and 4% in 2023.
Rewards to Shareholders: The company continues to increase shareholders’ value through dividend payments. In the first nine months of 2023, IDEX’s dividend payments totaled $142.3 million (up 7.6% year over year). The current quarterly dividend rate is 64 cents per share (a hike of 7% was announced in May 2023).
FLS delivered a trailing four-quarter average earnings surprise of 27.3%. In the past 60 days, the Zacks Consensus Estimate for Flowserve’s 2023 earnings has increased 3.1%. The stock has risen 20.5% in the past year.
Applied Industrial Technologies, Inc. (AIT - Free Report) presently carries a Zacks Rank #2 (Buy). It has a trailing four-quarter average earnings surprise of 13.9%.
The consensus estimate for AIT’s fiscal 2024 earnings has increased 3.7% in the past 60 days. Shares of Applied Industrial have jumped 22.9% in the past year.
A. O. Smith Corporation (AOS - Free Report) currently carries a Zacks Rank of 2. The company delivered a trailing four-quarter average earnings surprise of 14%.
In the past 60 days, the consensus estimate for A. O. Smith’s 2023 earnings has improved 5%. The stock has risen 22.5% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's Why Hold Strategy is Apt for IDEX (IEX) Stock Now
IDEX Corporation (IEX - Free Report) benefits from the Fire & Safety/Diversified Products (FSD) segment and accretive acquisitions despite weakness in the Health & Science Technologies unit, rising cost of sales and forex woes.
Let us discuss the factors why investors should retain the stock for the time being.
Growth Catalysts
Business Strength: IEX’s FSD segment is being driven by strong momentum in the fire and rescue businesses. In the third quarter of 2023, the segmental adjusted EBITDA margin increased 210 bps due to strong price cost performance, operational productivity and favorable volume leverage.
Accretive Acquisition: The company’s expansion initiative is expected to drive growth. The acquisition of Iridian Spectral (May 2023) expanded IDEX’s wide array of optical technology offerings. Iridian is part of IDEX Optical Technologies within the Health & Science Technology segment.
In November 2022, the company completed the acquisition of Muon Group, expanding its growing platform of precision technology business within the Health & Science Technologies segment. Commercial synergy potential from the combined entities is expected to boost offerings for new and existing customers. Notably, acquired assets boosted the company’s sales by 3% in the third quarter. The company anticipates buyout synergies to boost sales by 2% in the fourth quarter and 4% in 2023.
Rewards to Shareholders: The company continues to increase shareholders’ value through dividend payments. In the first nine months of 2023, IDEX’s dividend payments totaled $142.3 million (up 7.6% year over year). The current quarterly dividend rate is 64 cents per share (a hike of 7% was announced in May 2023).
IDEX Corporation Price and Consensus
IDEX Corporation price-consensus-chart | IDEX Corporation Quote
In light of the above-mentioned positives, we believe, investors should retain IEX stock for now, as suggested by its current Zacks Rank #3 (Hold).
Stocks to Consider
Some better-ranked companies from the Industrial Products sector are discussed below:
Flowserve Corporation (FLS - Free Report) presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
FLS delivered a trailing four-quarter average earnings surprise of 27.3%. In the past 60 days, the Zacks Consensus Estimate for Flowserve’s 2023 earnings has increased 3.1%. The stock has risen 20.5% in the past year.
Applied Industrial Technologies, Inc. (AIT - Free Report) presently carries a Zacks Rank #2 (Buy). It has a trailing four-quarter average earnings surprise of 13.9%.
The consensus estimate for AIT’s fiscal 2024 earnings has increased 3.7% in the past 60 days. Shares of Applied Industrial have jumped 22.9% in the past year.
A. O. Smith Corporation (AOS - Free Report) currently carries a Zacks Rank of 2. The company delivered a trailing four-quarter average earnings surprise of 14%.
In the past 60 days, the consensus estimate for A. O. Smith’s 2023 earnings has improved 5%. The stock has risen 22.5% in the past year.